Dr. Dan Thomson shares essential tips for injections, needle selection and syringe maintenance to ensure herd health and ...
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2025 ...
SQ Innovation's Lasix(R) ONYU Now Available for Order Through Major U.S. Pharmaceutical Distributors
SQ Innovation, Inc. today announced that following its FDA approval in October 2025, Lasix(R) ONYU (furosemide injection) is now available for ordering through Cardinal Health's Specialty ...
The updated labeling was supported by modeling data and in vivo results from the Dose Optimization study (see graph) and the INHALE-3 trial that demonstrated improved postprandial glucose outcomes ...
SQ Innovation’s Lasix® ONYU Now Available for Order Through Major U.S. Pharmaceutical Distributors
Addressing a Leading Cause of Hospitalization in Older Adults with Heart Failure BURLINGTON, Mass., Feb. 9, 2026 /PRNewswire/ -- SQ Innovation, Inc. today ...
A cancer treatment has been reformulated into a simple injection after its key components behaved differently in ...
Glucotrack, Inc. (Nasdaq: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...
Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization ...
1 Department of Urology, Children’s Hospital, Ho Chi Minh City, Vietnam 2 Department of Pediatric Surgery, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam Fournier's ...
Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way anti-cancer immunotherapy is administered from intravenous administration to ...
The U.S. Food and Drug Administration (FDA) recently approved the use of Darzalex Faspro (daratumumab and hyaluronidase-fihj) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results